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Effect of Conduction Mode and Location on
Electrophysiologic Characteristics of
Accessory Pathways
Arash Arya, MD, Majid Haghjoo, MD, Abdollah Jafari, MD, Zahra Emkanjoo, MD,
Amir Farjam Fazelifar, MD, Mohammad Reza Dehghani, MD,
and Mohammad Ali Sadr-Ameli, MD
The conduction properties of accessory pathways
(APs) are independent of location and conduction
mode (except in patients with multiple, Mahaim, and
slowly conducting APs). Patients with right-sided APs
show higher rates of atrial fibrillation and longer
arrhythmia cycle length due to slower anterograde
conduction over the atrioventricular node during
atrioventricular reentrant tachycardia. 2005 by
Excerpta Medica Inc.
(Am J Cardiol 2005;95:1250–1252)
The objective of this study was to determine thearrhythmia characteristics and electrophysiologic
properties of accessory pathways (APs) with respect
to their location and conduction mode (bidirectional
vs concealed) in patients with single APs. Because
most previous studies have assessed the influence of
AP location on electrophysiologic properties, such as
decremental and slow anterograde and/or retrograde
conduction,1–8 we excluded such patients (i.e., those
with Mahaim and slowly conducting APs) from our
study.
• • •
From March 2002 to March 2004, 136 consecutive
symptomatic patients with single APs (overt or con-
cealed) who underwent radiofrequency catheter abla-
tion were included in this study. All patients gave
written informed consent for electrophysiologic study
and ablation. The study was approved by our institu-
tional review committee. Eighty-three of the patients
were men (61%) (mean age 33.6 13.5 years). Struc-
tural heart disease was present in 8 patients (5.9%; 4
with mitral valve prolapse, 2 with Ebstein’s anomaly,
and 2 with valvular heart disease). The presenting
symptoms were palpitation, dizziness, syncope and/or
presyncope, and chest pain in 113, 10, 10, and 3
patients, respectively. The sudden onset and offset of
symptoms were noticed in 97 patients (71.3%) and 93
patients (68.4%), respectively. The mean duration of
symptoms before catheter ablation was 6  5 years.
All antiarrhythmic medications were withdrawn
before the electrophysiologic study for 5 half-lives.
Three 6Fr quadripolar catheters (DAIG, St. Jude Med-
ical, Inc., St. Paul, Minnesota) were introduced
through the femoral veins and positioned at the right
ventricular apex, the His bundle, and the high right
atrium. A 7Fr steerable decapolar catheter (Marinr,
Medtronic, Inc., Minneapolis, Minnesota) was intro-
duced through the right femoral vein and positioned in
the coronary sinus. Twelve-lead surface electrocardio-
grams and bipolar filtered (30 to 500 Hz) and unipolar
unfiltered electrograms were recorded, displayed, and
stored on an electrophysiologic recording system
(EPMed Systems, Inc., West Berlin, New Jersey).
Mapping was done during sinus rhythm and arrhyth-
mia. The locations of APs were determined on the
basis of standard fluoroscopic views (Figure 1).6 The
presence of dual atrioventricular nodal physiology and
concomitant arrhythmias was assessed. The antero-
grade and retrograde effective refractory periods
(ERPs) of APs, the mode of conduction, and the
arrhythmia cycle length were measured. An Atakr II
(Medtronic, Inc.) radiofrequency energy generator (486
kHz) was used for radiofrequency catheter ablation.
We defined the anterograde ERP of an AP as the
longest atrial extrastimulus coupling interval that
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failed to conduct over the AP (absence of ventricular
preexcitation), the retrograde ERP of an AP as the
longest ventricular extrastimulus coupling interval
that failed to conduct in a retrograde manner over the
AP, and dual atrioventricular nodal physiology as a
50-ms increase in the atrium–His bundle (AH) in-
terval during programmed atrial stimulation in re-
sponse to a 10-ms decrease in the atrial extrastimulus
coupling interval.
Variables are expressed as mean  SD and per-
centage. Differences in characteristics between 2
groups were assessed by the independent-samples Stu-
dent’s t test for continuous variables and the chi-
square test (or Fisher’s exact test if necessary) for
discrete variables. A 2-tailed p value 0.05 was con-
sidered significant.
During the study, 168 patients with APs were stud-
ied and underwent radiofrequency catheter ablation at
our center. Of these, 146 (87%) had single APs and 22
(13%) had multiple APs. In the former group, we
further excluded 10 patients with Mahaim (n  8) or
slowly conducting (n  2) APs. We included the
remaining 136 patients in our final analysis. Of these,
112 patients (82%) had bidirectional APs, and 24
patients (18%) had concealed APs. Seventy-one pa-
tients (52%) had left-sided APs, and the remaining 65
patients (48%) had right-sided APs. Septal and free-
wall APs were observed in 49 patients (36%) and 87
patients (64%), respectively (Figure 1).
Orthodromic and antidromic atrioventricular reen-
trant tachycardia (AVRT) were induced during pro-
grammed electrical stimulation in 100 patients (73.5%)
and 3 patients (2.5%), respectively. The arrhythmia
cycle length was 335  56 ms. Arrhythmia other than
AVRT was observed in 25 patients (atrioventricular
nodal reentrant tachycardia in 2 [1.5%] and atrial
fibrillation in 23 [17%]). Dual atrioventricular nodal
physiology was observed in 33 patients (24%).
Table 1 lists electrophysiologic findings on the
basis of AP location and mode of conduction. Antero-
grade and retrograde ERPs of APs, gender distribution,
and the conduction modes of APs were comparable
between different locations. Patients with right-sided
APs had longer arrhythmia cycle lengths and higher
rates of atrial fibrillation. The prevalence of dual atrio-
ventricular nodal physiology was comparable among
all locations and conduction modes of AP. In patients
with right- and left-sided APs, the AH intervals during
sinus rhythm were 80  16 and 85  21 ms, respec-
tively (p  0.305). During arrhythmia, the AH inter-
vals in patients with right- and left-sided APs were
196  34 and 155  40 ms, respectively (p 0.001).
• • •
In patients with single APs (excluding Mahaim and
slowly conducting APs), conduction properties did not
depend on the locations and conduction modes of
APs. The prevalence of dual atrioventricular nodal
physiology was comparable among all locations and
conduction modes of AP. Patients with right-sided
APs had longer arrhythmia cycle lengths and higher
rates of atrial fibrillation.
Previous studies have shown that the location of an
AP influences some of its electrophysiologic proper-
ties (i.e., decremental and/or slow conduction).8 How-
ever, our data showed that the conduction properties
of APs (excluding those with decremental and/or slow
conduction) are not affected by their location and/or
conduction modes. De Chillou et al8 suggested that in
patients with left free-wall APs, symptoms occur later
in life compared with those with other APs. However,
our findings did not show such a trend. The ages at
presentation were 34.6  13 and 33.4  13.7 years in
patients with left free-wall versus other APs, respec-
tively (p  0.62). The duration of symptoms in the 2
groups was also comparable (5.6  4.8 vs 6.8  5.2
years, p  0.17).
Contrary to previous studies,1 the rate of inducible
AVRT during the electrophysiologic study was com-
parable in patients with (55.6%) and without (76.5%)
atrial fibrillation (p  0.34), and inducible atrial fi-
brillation during electrophysiologic study was more
prevalent in patients with concealed APs. These vari-
ations may be explained by different electrophysi-
ologic protocols and patient populations.
We found that arrhythmia cycle lengths were
longer in patients with right-sided APs compared with
the rest of the patients. Because the retrograde ERP in
left- and right-sided APs was comparable (Table 1),
we postulated that the difference might be due to
slower anterograde atrioventricular nodal conduction.
Our findings supported our assumption and showed
that in AVRTs incorporating right-sided APs, the AH
interval was longer than those incorporating left-sided
APs. Liu et al5 also recently showed that in patients
with right free-wall APs, the anterograde conduction
over the atrioventricular node is slower compared with
those with other AP locations.
FIGURE 1. Representation of AP distribution along the left and
right atrioventricular grooves in the left anterior oblique (LAO)
view. CS  coronary sinus; LI  left inferior; LP  left posterior;
LPI  left posteroinferior; LPS  left posterosuperior; LPSP  left
paraseptal; MA  mitral annulus; RA  right anterior; RAS 
right anterosuperior; RASP  right anteroseptal; RI  right infe-
rior; RMS  right midseptal; RPSP  right paraseptal; RS  right
superior; TA  tricuspid annulus.
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Comparison of Clinical Presentation of Acute
Myocarditis Following Smallpox Vaccination to Acute
Coronary Syndromes in Patients <40 Years of Age*
Robert E. Eckart, DO, Eric A. Shry, MD, Samuel O. Jones IV, MD, J. Edwin Atwood, MD,
and John D. Grabenstein, RPh, PhD
Smallpox vaccine–associated myopericarditis may
have a similar presentation to acute coronary syn-
drome (ACS). The clinical records of 78 young pa-
tients (<40 years of age) presenting with ACS (n 
16) or myocarditis after smallpox vaccination (n 
62) were reviewed. Comparisons were made among
clinical presentation, cardiac enzymes, echocardio-
graphic findings, and electrocardiographic changes.
The presence of cardiac risk factors or focal wall
motion abnormalities on echocardiography were as-
sociated with a diagnosis of ACS. There was a trend
toward earlier elevation of troponin-I and creatine
kinase in patients with myocarditis compared with
ACS. 2005 by Excerpta Medica Inc.
(Am J Cardiol 2005;95:1252–1255)
Chest pain is a frequent complaint in young patientsseeking medical attention. Even after initial eval-
uation with histories and physical and laboratory stud-
ies, there is considerable clinical overlap between
young patients with acute coronary syndrome (ACS)
and those presenting with myocarditis.1–4 Recent re-
ports have described the greater than expected inci-
dence of myopericarditis after smallpox vaccination in
United States military personnel,5–7 and all these pa-
tients were identified after presentation for chest
symptoms. However, little information exists to dif-
ferentiate these patients from those with premature
atherosclerosis causing ACS. The purpose of this
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TABLE 1 Electrophysiologic Findings Based on AP Location and Mode of Conduction
Variable
Septal vs Free Wall Left vs Right Overt vs Concealed
Septal Free Wall p Value Left Right p Value Overt Concealed p Value
Anterograde ERP (ms) 291  84 292  80 0.96 288  81 295  83 0.69 — — —
Retrograde ERP (ms) 291  56 303  58 0.34 306  59 290  54 0.22 304  52 297  58 0.66
Arrhythmia cycle length (ms) 347  58 330  54 0.15 322  55 352  55 0.045* 339  40 336  59 0.84
Atrial fibrillation (n, %) 12 11 0.35 6 17 0.028* 14 (12.5%) 9 (37.5%) 0.037*
Men/women (n) 29/20 55/32 0.24 46/25 38/27 0.30 67/45 17/7 0.36
Dual atrioventricular nodal
physiology (%)
25% 22% 0.41 20% 25% 0.33 22% 25% 0.47
Concealed (%) 23% 15% 0.251 16% 20% 0.65 — — —
Inducible AVRT (%) 74% 73% 0.728 74% 72% 0.477 68% 73% 0.630
*p value (2-tailed) 0.05 was considered significant.
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